Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Daniel F. Hoth"'
Autor:
Gregory J. Downing, Carl C. Peck, Arthur J. Atkinson, Robert T. Schooley, Daniel F. Hoth, Victor G. DeGruttola, John A. Oates, Janet Woodcock, Wayne A. Colburn, Scott L. Zeger, David L. DeMets, Bert A. Spilker
Publikováno v:
Clinical Pharmacology & Therapeutics. 69:89-95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b596d8a47e1883cd99f7fbf9d9fa363e
https://doi.org/10.1067/mcp.2001.113989
https://doi.org/10.1067/mcp.2001.113989
Autor:
Margaret I. Johnston, Daniel F. Hoth
Publikováno v:
Science. 260:1286-1293
Since the discovery of human immunodeficiency virus (HIV) in 1983, significant progress has been made toward the discovery, development, and licensing of anti-HIV drugs. In vitro screens against whole virus are now being complemented by screens again
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::584141f67c775edbb153990080f64e62
https://doi.org/10.1126/science.7684163
https://doi.org/10.1126/science.7684163
Publikováno v:
Statistics in Medicine. 12:461-467
Randomized clinical trials are being conducted and/or sponsored by all scientific divisions of the National Institute of Allergy and Infectious Diseases (NIAID). External committees to review the progress of ongoing trials and to make recommendations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23641615c0d68760a6bbe3e6c23ac328
https://doi.org/10.1002/sim.4780120510
https://doi.org/10.1002/sim.4780120510
Publikováno v:
Hospital Practice. 27:145-156
The clinician's armamentarium is no longer limited to zidovudine as the only antiretroviral agent that enhances both quality and length of life. ddI has shown clinical benefit in patients previously treated with zidovudine. Recently, the combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db7e76100a662c78b3fcdb734043d735
https://doi.org/10.1080/21548331.1992.11705488
https://doi.org/10.1080/21548331.1992.11705488
Autor:
Daniel F. Hoth, Dianne M. Finkelstein, Sandra Nusinoff-Lehrman, Henry S. Sacks, Susan S. Ellenberg, James Eigo, Ellen C. Cooper
Publikováno v:
Controlled Clinical Trials. 13:272-292
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fa7e80dce8b633603c8054a7c6d1efb
https://doi.org/10.1016/0197-2456(92)90011-n
https://doi.org/10.1016/0197-2456(92)90011-n
Autor:
Judith Feinberg, Daniel F. Hoth
Publikováno v:
Hospital Practice. 26:105-113
Infections and malignancies account for most deaths in patients with AIDS and will continue to do so as long as HIV-induced immunosuppression is progressive and irreversible. Co-trimoxazole has emerged as the preferred agent for prevention of Pneumoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92977830f6021523fcc82ff04e5c3cc2
https://doi.org/10.1080/21548331.1991.11707716
https://doi.org/10.1080/21548331.1991.11707716
Autor:
Sten H. Vermund, Daniel F. Hoth
Publikováno v:
Annals of Epidemiology. 1:141-155
In a single decade, the pandemic of human immunodeficiency virus (HIV) infection has become an international health, social, and economic emergency. Early and effective intervention is urgently needed for both prevention of HIV infection and for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6f3e83b10c97179b438bc32ab4de2fc
https://doi.org/10.1016/1047-2797(90)90005-d
https://doi.org/10.1016/1047-2797(90)90005-d
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 5, Iss Suppl A, Pp 36A-41A (1994)
The goal of a prophylactic human immunodeficiency (HIV) vaccine is to elicit immune response(s) that will, upon subsequent exposure to HIV. prevent lnfection and/or disease. On the other hand. therapeutic administration of a vaccine to an individual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9415ac44f0976629de35d0673d84db5f
https://doaj.org/article/20dcb6834019413da8c4b6ef1195a3e8
https://doaj.org/article/20dcb6834019413da8c4b6ef1195a3e8
Autor:
Daniel F. Hoth
Publikováno v:
Annals of the New York Academy of Sciences. 685
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc8a91b904106ae886c2cb7f2d031f3c
https://pubmed.ncbi.nlm.nih.gov/8363285
https://pubmed.ncbi.nlm.nih.gov/8363285
Autor:
Maureen Myers, Daniel F. Hoth
Publikováno v:
Hospital practice (Office ed.). 26(1)
Zidovudine has proved to be an important palliative agent in all stages of HIV infection. It delays progression of disease in patients with asymptomatic or mildly symptomatic infection and decreases the frequency and severity of opportunistic disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d34db35702853cf883575600c4214bf
https://pubmed.ncbi.nlm.nih.gov/1702791
https://pubmed.ncbi.nlm.nih.gov/1702791